BioRestorative Therapies Inc

NASDAQ:BRTX 4:00:00 PM EDT

2.07

+0.28 (+15.64%)

7:34:20 PM EDT: $2.08 +0.01 (+0.48%)

Market Cap (Intraday)	9.66M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.03 Million
Adjusted EPS	-$0.76

See more estimates

10-Day MA	$1.79
50-Day MA	$2.24
200-Day MA	$3.41

See more pivots

BioRestorative Therapies Inc Stock, NASDAQ:BRTX

40 Marcus Drive, Suite 1, Melville, New York 11747

United States of America

Phone: +1.631.760.8100

Number of Employees: 10

http://www.biorestorative.com

Description

Biorestorative Therapies Inc. engages in developing therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders including obesity and diabetes. Its initial investigational therapeutic product being called BRTX-100 focuses on treating damage by autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process., The company was founded on June 13, 1997 and is headquartered in Melville, NY.